Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-22 05:14:10 UTC |
---|
Update Date | 2016-11-09 01:15:48 UTC |
---|
Accession Number | CHEM018418 |
---|
Identification |
---|
Common Name | Cefsulodin sodium |
---|
Class | Small Molecule |
---|
Description | |
---|
Contaminant Sources | - STOFF IDENT Compounds
- ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
CGP 7174 e | MeSH | Cefsulodin | MeSH | Cefsulodin monosodium salt | MeSH | SCE 129 | MeSH | Monosodium salt, cefsulodin | MeSH | SCE-129 | MeSH | Sodium, cefsulodin | MeSH | CGP-7174-e | MeSH | Monaspor | MeSH | Abbott 46811 | MeSH | Pyocefal | MeSH | Salt, cefsulodin monosodium | MeSH | Cefsulodin sodium | MeSH | Takeda brand OF cefsulodin sodium | MeSH |
|
---|
Chemical Formula | C22H19N4NaO8S2 |
---|
Average Molecular Mass | 554.520 g/mol |
---|
Monoisotopic Mass | 554.054 g/mol |
---|
CAS Registry Number | 52152-93-9 |
---|
IUPAC Name | sodium 1-{[(6S,7R)-2-carboxy-7-{[(2S)-1-hydroxy-2-phenyl-2-sulfonatoethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium-4-carboximidate |
---|
Traditional Name | sodium 1-{[(6S,7R)-2-carboxy-7-{[(2S)-1-hydroxy-2-phenyl-2-sulfonatoethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium-4-carboximidate |
---|
SMILES | [Na+].[H][C@@](C(O)=N[C@]1([H])C(=O)N2C(C(O)=O)=C(C[N+]3=CC=C(C=C3)C([O-])=N)CS[C@@]12[H])(C1=CC=CC=C1)S([O-])(=O)=O |
---|
InChI Identifier | InChI=1S/C22H20N4O8S2.Na/c23-18(27)13-6-8-25(9-7-13)10-14-11-35-21-15(20(29)26(21)16(14)22(30)31)24-19(28)17(36(32,33)34)12-4-2-1-3-5-12;/h1-9,15,17,21H,10-11H2,(H4-,23,24,27,28,30,31,32,33,34);/q;+1/p-1/t15-,17+,21+;/m1./s1 |
---|
InChI Key | REACMANCWHKJSM-DEEQTVBNSA-M |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid moiety or a derivative thereof. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Lactams |
---|
Sub Class | Beta lactams |
---|
Direct Parent | Cephalosporins |
---|
Alternative Parents | |
---|
Substituents | - Cephalosporin
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid or derivatives
- Phenylacetamide
- Pyridine carboxylic acid or derivatives
- Meta-thiazine
- Monocyclic benzene moiety
- Pyridine
- Pyridinium
- Benzenoid
- Heteroaromatic compound
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Alkanesulfonic acid
- Organosulfonic acid
- Sulfonyl
- Tertiary carboxylic acid amide
- Carboxamide group
- Carboxylic acid salt
- Primary carboxylic acid amide
- Azetidine
- Secondary carboxylic acid amide
- Thioether
- Hemithioaminal
- Dialkylthioether
- Carboxylic acid derivative
- Organic alkali metal salt
- Azacycle
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic salt
- Organopnictogen compound
- Organonitrogen compound
- Organic oxygen compound
- Organooxygen compound
- Organosulfur compound
- Organic oxide
- Carbonyl group
- Organic nitrogen compound
- Organic zwitterion
- Hydrocarbon derivative
- Organic sodium salt
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-016r-0172290000-5da144e76f1c545f4ac5 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-07vi-2296000000-4610b4a9e211902dcac1 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0596-6942000000-3da94bbc1b933a97ec58 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0090000000-d3574a6b837f58350df7 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00di-1930000000-71a6b1f84e9cbff49b7f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0fk9-7921000000-d465070f0b5970ef2f07 | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
Chemspider ID | Not Available |
---|
ChEBI ID | Not Available |
---|
PubChem Compound ID | 6604087 |
---|
Kegg Compound ID | Not Available |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | Not Available |
---|